Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZBH · against 115 other Healthcare companies of similar size
Ranked #25 of 116 · scores higher than 78% of peers
Bars: peers in each 10-point band of the valuation score19 peers with a valuation score of 70–79, including ZBH · Click a bar to see the companies
Mainly thanks to its free cash flow yield, EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | ZBH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 114 reported | 4.2% | 3.2% | 71% | 30% | |
| EBITDA yieldHigher is better · 116 reported | 9.8% | 5.6% | 85% | 50% | |
| Free cash flow yieldHigher is better · 75 reported | 7.6% | 3.8% | 86% | 20% | |
| Book yieldHigher is better · 110 reported | 68.2% | 21.6% | 93% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 2 | 10.4B USD | 96 | 64 | |
| 3 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 3 | 21.5B USD | 95 | 60 | |
| 5 | 11.6B USD | 94 | 58 | |
| 22 | 27.5B EUR (≈$30.2B) | 76 | 60 | |
| 23 | 99.2B CNY (≈$13.9B) | 74 | 67 | |
| 23 | 36.4B USD | 74 | 50 | |
| 25 | 13.3B USD | 73 | 59 | |
| 25 | 18.5B USD | 73 | 54 | |
| 27 | 10.8B USD | 72 | 54 | |
| 27 | 14.9B USD | 72 | 65 | |
| 29 | 5.26T JPY (≈$35.8B) | 71 | 63 | |
| 29 | 975.0B INR (≈$11.7B) | 71 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score